• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BOLT

BOLT

Bolt Biotherapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.63

-0.48 (-9.39%)

Rating:C

Company Profile

CEO

William Quinn

IPO Date

2021-02-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.26

Prev. Close

$5.11

Day Low

$4.63

Day High

$5.26

52W Low

$3.91

52W High

$7.35

Market Cap

$0.01B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

6

Avg Positive

45.2%

Avg Negative

1.0%

Avg Neutral

54.0%

News Feed

Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs

PRNewsWire·8/26/2021·↑ positive

Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs

GlobeNewsWire·8/26/2021·↑ positive

Bolt Biotherapeutics: Pioneering A New Class Of Immunotherapies

Seeking Alpha·8/18/2021·↑ positive

Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001

GlobeNewsWire·4/10/2021·↑ positive

Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/8/2021·↑ positive

Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights

GlobeNewsWire·3/31/2021·↑ positive